References
- Ballardini G, Faccani A, Bianchi FB, Fallani M, Patrono D, Capelli M, Pisi E. (1984) Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen III peptide in chronic liver disease. Liver 4, 348-352.
- Batta AK, Saken G, Arora R, Sheffer S. (1998) Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatol. 10, 414-419. https://doi.org/10.1002/hep.1840100404
- Beukers R, Schalm SW. (1992) Immunosuppressive therapy for primary biliary cirrhosis. J. Hepatol. 14, 1-6. https://doi.org/10.1016/0168-8278(92)90123-7
- Bickel M, Baringhaus KH, Gerl M, Kanta J, Schmidts L, Stapf M, Tschank G, Weidmann K, Werneer U. (1998) Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor. Hepatol. 28, 404-411. https://doi.org/10.1002/hep.510280217
- Bissell DM, Maher JJ. (1996) Hepatic fibrosis and cirrhosis. Hepatology Philadelphia: Saunders, 506-525.
- Leveille CR, Arias IM. (1967) Pathophysiology and pharmacologic modulation of hepatic fibrosis. J. Vet. Int. Med. 7, 73-84. https://doi.org/10.1111/j.1939-1676.1993.tb03173.x
- Dickson ER, Flemming TR, Wiesner RH, Baldus WP. (1985) Trial of penicillamine in advanced primary biliary cirrhosis. N. Engl. J. Med. 312, 1011-1015. https://doi.org/10.1056/NEJM198504183121602
- Fort J, Pilette C, Veal N, Oberti F, Gallois Y, Douay O, Rosenbaum J Cales P. (1998) Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats. J. Hepatol. 29, 263-270. https://doi.org/10.1016/S0168-8278(98)80012-3
- Friedman SL. (1993) The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med. 328, 1828-1835. https://doi.org/10.1056/NEJM199306243282508
- Vassalli JD, Sappino AP, Bellin D. (1991) The plasminogen activator/plasmin system. J. Clin. Invest. 88, 1067-1072. https://doi.org/10.1172/JCI115405
- Vassalli JD, Popper MS. (1994) Membrane proteases in focus. Nature(London) 370, 14-15. https://doi.org/10.1038/370014a0
- Kountaras J, Barbara H, Billing JS, Billing P. (1984) Prolonged gile duct obstruction: a new experimental model for cirrhosis in the rat. Br. J. Exp. Pathol. 65, 305-311.
- Jamall IS, Finelli VN. (1981) A single method to determine nanogram levels of 4- hydroxyproline in biological tissue. Anal. Biochem. 112, 70-75. https://doi.org/10.1016/0003-2697(81)90261-X
- Kim SN, Kim SY, Yim HK, Lee WY, Ham KS, Kim SK, Yoon MY, Kim YC. (1999) Effect of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarbox-ylate (DDB) on chemical-induced liver injury. Biol. Pharm. Bull. 22, 93-95. https://doi.org/10.1248/bpb.22.93
- Kountouras J, Billing BH, Scheuer PJ. (1984) Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. J. Exp. Pathol. 65, 305-311.
- Rodriguez-Fragoso L, Gonzalez MP, Muriel P. (1995) Interferon-2b increase fibrolysis in fibrotic livers from bile duct ligated rats. Possible participation of the plasminogen activator. Pharmacology 51, 341-346. https://doi.org/10.1159/000139345
- Maher JJ, Mcguire RF. (1990) Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endotherial cells during hepatic fibrosis in vivo. J. Clin. Invest. 86, 1641-1648. https://doi.org/10.1172/JCI114886
- Muriel P, Suarez OR, Gonzalez P, Zuniga L. (1994) Protective effect of S-adenosyl-L-methionie on liver damage induced by biliary obstruction in rats. J. Hepatol. 21, 95-102. https://doi.org/10.1016/S0168-8278(94)80143-6
- Nan JX, Park FJ, Kim HJ, Ko G, Sohn DH. (2000) Antifibrotic effects of the methanol extract of Polygonum aviculare in fibrotic rats induced by bile duct ligation and scission. Biol. Pharm. Bull. 23, 240-243. https://doi.org/10.1248/bpb.23.240
- Neubauer J, Cristensen E, Portmann B, Caballeri J, Rodes J, Ranek L. (1985) Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut 26, 114-119. https://doi.org/10.1136/gut.26.2.114
- Peterson TC, Neumeister M. (1996) Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in rat mechanism. Immunopharmacol. 31, 183-193. https://doi.org/10.1016/0162-3109(95)00048-8
- Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. (1992) Inhibition of rat hepatic limpocyte activation in culture by interferon-gamma. Hepatol. 16, 776-784. https://doi.org/10.1002/hep.1840160325
- Rodriguez L, Cerbon AJ, Munoz ML. (1998) Effects of colchine and colchiceine in a biochemical model of liver injury and fibrosis. Arch. Med. Res. 29, 109-116.
- Friedman SL, Bissel M. (1990) Hepatic fibrosis: new insight into pathogenesis. Hosp. Pract. 15, 43-51.
- Schuppan D. (1995) Chronische Hepatitis-Antifibrotische Therapieausaetze Z. Allg. Med. 71, 11531-11542.
- Schuppan D. (1990) Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteuns. Semin Liver Dis. 19, 1-10.
- Shimizu I, Mizobuchi Y, Yasuda M, Ma YR, Horie T, Liu F, Ito S. (1999) Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut 44, 127-136. https://doi.org/10.1136/gut.44.1.127
- Wiesner RM, Dickson ER, Lindor D, Jorgensen R, LaRusso NF, Baldus W. (1987) A controlled clinical trial evaluating cyclosporin in the treatment of primary biliary cirrhosis: A preliminary report. Hepatol. 7, 1025 (Abstr).
- Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. (1996) Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatol. 24, 636-642. https://doi.org/10.1002/hep.510240328